Outcome of preoperative concurrent chemoradiotherapy and surgery for resectable lingual squamous cell carcinoma greater than 3 cm: The possibility of less extensive surgery

Oral Oncology

Volumn 42, Issue 4, 2006, Pages 391-397

  Iguchi, Hiroyoshi ^a   Kusuki, Makoto ^a   Nakamura, Aki ^a   Kanazawa, Akimori ^a   Hachiya, Kazutaka ^a   Yamane, Hideo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; Adverse effect; Anthracyclin; Cancer; Chemotherapy; Radiotherapy; Response rate; THP; Tongue

Indexed keywords

FLUOROURACIL; PIRARUBICIN;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RECURRENT CANCER; TONGUE CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 33645066389     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.09.006     Document Type: Conference Paper

References (29)

1. T. Nakagawa, H. Shibuya, and R. Yoshimura Neck node metastasis after successful brachytherapy for early stage tongue carcinoma Radiother Oncol 68 2 2003 129 135
2. M. Goto, Y. Hasegawa, and A. Terada Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers Oral Oncol 41 1 2005 62 69
3. S.G. Urba, J. Moon, and P.G. Giri Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial J Clin Oncol 23 1 2005 88 95
4. H. Iguchi, M. Kusuki, and A. Nakamura Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma Acta Otolaryngol 554 Suppl 2004 55 61
5. K.T. Robbins, S. Samant, F. Vieira, and P. Kumar Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT) Arch Otolaryngol Head Neck Surg 130 1 2004 28 32
6. B. Damascelli, G.L. Patelli, and R. Lanocita A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings AJR Am J Roentgenol 181 1 2003 253 260
7. K. Furutani, N. Fuwa, and T. Kodaira Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base Oral Oncol 38 2 2002 145 152
8. T. Shimizu, Y. Sakakura, T. Hattori, N. Yamaguchi, M. Kubo, and K. Sakakura Superselective intraarterial chemotherapy in combination with irradiation: preliminary report Am J Otolaryngol 11 2 1990 131 136
9. M. Brandwein-Gensler, M.S. Teixeira, and C.M. Lewis Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival Am J Surg Pathol 29 2 2005 167 178
10. T. Kirita, H. Shimooka, and Y. Yamanaka Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 3 2001 293 300
11. T. Kirita, K. Ohgi, M. Tsuyuki, N. Kamikaido, K. Yamamoto, and M. Sugimura Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity J Surg Oncol 63 4 1996 240 248
12. T. Kirita, K. Ohgi, and M. Kawakami Primary tumour resection of tongue carcinoma based on response to preoperative therapy Int J Oral Maxillofac Surg 31 3 2002 267 272
13. J.J. Gemmete Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer J Vasc Interv Radiol 14 6 2003 743 748
14. P. Schoffski The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors Anticancer Drugs 15 2 2004 85 106
15. J.A. Koutcher, A.A. Alfieri, H. Thaler, C. Matei, and D.S. Martin Radiation enhancement by biochemical modulation and 5-fluorouracil Int J Radiat Oncol Biol Phys 39 5 1997 1145 1152
16. M. Nagasawa, S. Ishii, and Y. Kariya In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines Jpn J Cancer Chemother 17 4 1990 633 638
17. D. Marchiset-Leca, F.R. Leca, A. Galeani, A. Noble, and J. Catalin Pharmacokinetics and metabolism of pirarubicin in humans: correlation with pharmacodynamics Cancer Chemother Pharmacol 36 3 1995 239 243
18. D.A. Cameron, H. Gabra, and R.C. Leonard Continuous 5-fluorouracil in the treatment of breast cancer Br J Cancer 70 1 1994 120 124
19. A. Sparano, G. Weinstein, A. Chalian, M. Yodul, and R. Weber Multivariate predictors of occult neck metastasis in early oral tongue cancer Otolaryngol Head Neck Surg 131 4 2004 472 476
20. K. Yoshida, K. Kashima, S. Suenaga, N. Nomi, J. Shuto, and M. Suzuki Immunohistochemical detection of cervical lymph node micrometastases from T2N0 tongue cancer Acta Otolaryngol 125 6 2005 654 658
21. M.J. Veness, G.J. Morgan, Y. Sathiyaseelan, and V. Gebski Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg 75 3 2005 101 105
22. S.W. Beenken, H. Krontiras, W.A. Maddox, G.E. Peters, S. Soong, and M.M. Urist T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection Head Neck 21 2 1999 124 130
23. N. Mozzillo, F. Chiesa, and C. Caraco Therapeutic implications of sentinel lymph node biopsy in the staging of oral cancer Ann Surg Oncol 11 Suppl. 3 2004 263S 266S
24. H. Yamazaki, T. Inoue, and K. Yoshida Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy Int J Radiat Oncol Biol Phys 58 1 2004 139 146
25. S.C. Lim, S. Zhang, and G. Ishii Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue Clin Cancer Res 10 1 2004 166 172
26. T.M. Pimenta Amaral, A.R. Da Silva Freire, A.L. Carvalho, C.A. Pinto, and L.P. Kowalski Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth Oral Oncol 40 8 2004 780 786
27. H. Kurokawa, Y. Yamashita, S. Takeda, M. Zhang, H. Fukuyama, and T. Takahashi Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue Head Neck 24 8 2002 731 736
28. T. Asakage, T. Yokose, and K. Mukai Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue Cancer 82 8 1998 1443 1448
29. J.F. Gallegos-Hernandez, D.M. Hernandez-Hernandez, and R. Flores-Diaz The number of sentinel nodes identified as prognostic factor in oral epidermoid cancer Oral Oncol 41 9 2005 947 952